Philip K. Moskowitz, MD, is an associate professor in the Department of Medicine. He is not only an outstanding physician, but also a compassionate and kind human being. Dr. Moskowitz is a highly respected member of our NYU Langone faculty who has made a difference for 50 years and counting.

Dr. Moskowitz has cared for multiple generations of families. Additionally, as a member of the executive committee for medical school admissions for three decades, he is actively involved in the recruitment of the next generation of physicians to NYU Grossman School of Medicine.

He has also served as faculty director of development at NYU Langone for more than two decades. He was instrumental in securing major funding for the medical center’s new emergency department, the Ronald O. Perelman Department of Emergency Medicine, and professorships within the school of medicine. He worked closely with his personal friends Judith and Stewart Colton when they shared their vision for a center dedicated to interdisciplinary autoimmunity research.

Together with the Coltons, they have generously established the Moskowitz Scholar Award, which recognizes and supports the next generation of researchers in the field of autoimmunity.

Our Scholars

David B. Beck, MD, PhD, received his MD/PhD at NYU School of Medicine where he studied biochemistry in the laboratory of Dr. Danny Reinberg. He performed further clinical training at Columbia University in internal medicine and the National Institutes of Health in clinical genetics. Dr. Beck performed his postdoctoral research with Dr. Dan Kastner at the National Human Genome Research Institute studying the genetics and mechanism underlying a subset of rheumatic diseases called autoinflammatory syndromes. Dr. Beck’s work focused on discovering and characterizing new genetic diseases, including VEXAS syndrome. Dr. Beck joined the faculty at NYU Grossman School of Medicine in September 2021 to run a translational program studying autoinflammatory diseases, including VEXAS syndrome, both in the clinic and in the laboratory. His independent work focuses on trying to identify genetic causes of diseases in patients and use laboratory investigation to help provide insights for clinical care.

Rebecca Haberman, MD, MSCI, is an assistant professor in the Department of Medicine, associate director of the Psoriatic Arthritis Center, and assistant director of the Arthritis Clinic at NYU Langone Orthopedic Hospital. She received her MD from NYU Grossman School of Medicine, where she also completed her internal medicine residency and rheumatology fellowship and earned a master’s degree in clinical investigation. Her research has been supported by the NIH, the Rheumatology Research Foundation, and the National Psoriasis Foundation. Her current research is focused on improving outcomes in patients with psoriatic arthritis (PsA) by understanding, profiling, and visualizing depression and pain present in the condition. Dr. Haberman also focuses on the prevention and early treatment of PsA as a pathway to improve outcomes. Her other research interests include using digital health applications and wearables to monitor PsA symptoms and early response to drug therapy, understanding differences in disease presentation and phenotype in racially and ethnically diverse patients, and identifying the impact of COVID-19 infection and vaccination of patients with immune-mediated inflammatory disease.